TY - JOUR
AU - Cook, David A.
AB - Editorial One Drop at a Time: Research to Advance the Science of Simulation David A. Cook, MD, MHPE The article by Weinger in this issue describes a useful framework for thinking about research in simulation. It emphasizes the need for purposeful and program- matic accumulation of information to guide our use of simulation. The analogy with a drug is apt, albeit inexact, given the variations in dose (instructional design and intensity), dosing (repetition), disease (learning objectives), and drug-host, drug- drug, and drug-environment interactions (learner, other learning, and larger con- text), we encounter in the development of simulation activities. However, although this framework outlines information required to advance our understanding of how to use simulation, it does not spell out the research designs that will be required to accomplish this lofty but laudable objective. In this editorial, I will discuss the types of research needed to accrue the information Weinger requests. A CRITIQUE OF WEINGER’S FRAMEWORK However, there are limitations that must be recognized in Weinger’s framework. First, simulation is not a drug. One cannot prescribe 20 mg of simulation the way a physician might prescribe 20 mg of lisinopril. Not only does the word simulation encompass a vast range 
TI - One Drop at a Time: Research to Advance the Science of Simulation
JF - Simulation in Healthcare
DO - 10.1097/SIH.0b013e3181c82aaa
DA - 2010-02-01
UR - https://www.deepdyve.com/lp/wolters-kluwer-health/one-drop-at-a-time-colon-research-to-advance-the-science-of-simulation-J2QtZ5ErSg
SP - 1-4
EP - 1-4
VL - 5
IS - 1
DP - DeepDyve
ER -